Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A retrospective observational study evaluating hypoglycaemia rates in people with type 2 diabetes (T2DM) prescribed basal insulin (BI) analogues

Trial Profile

A retrospective observational study evaluating hypoglycaemia rates in people with type 2 diabetes (T2DM) prescribed basal insulin (BI) analogues

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2018

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin degludec; Insulin detemir
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LIGHTNING
  • Most Recent Events

    • 05 Oct 2018 Results assessing hypoglycaemic events presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
    • 12 Dec 2017 Results from LIGHTNING and Deliver D studies published in a Sanofi media release.
    • 05 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top